TW249754B - - Google Patents
Info
- Publication number
- TW249754B TW249754B TW082108901A TW82108901A TW249754B TW 249754 B TW249754 B TW 249754B TW 082108901 A TW082108901 A TW 082108901A TW 82108901 A TW82108901 A TW 82108901A TW 249754 B TW249754 B TW 249754B
- Authority
- TW
- Taiwan
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/141,013 US5468729A (en) | 1993-10-26 | 1993-10-26 | Method for treatment of autoimmune hepatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW249754B true TW249754B (enExample) | 1995-06-21 |
Family
ID=22493765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW082108901A TW249754B (enExample) | 1993-10-26 | 1993-10-26 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5468729A (enExample) |
| AU (1) | AU8086894A (enExample) |
| MY (1) | MY115157A (enExample) |
| PH (1) | PH31319A (enExample) |
| SG (1) | SG46620A1 (enExample) |
| TW (1) | TW249754B (enExample) |
| WO (1) | WO1995011696A1 (enExample) |
| ZA (1) | ZA948252B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9806632D0 (en) * | 1998-03-28 | 1998-05-27 | Stevenson Robert | Peptide factor |
| DK1448205T3 (da) | 2001-10-05 | 2011-12-12 | Zalicus Inc | Kombinationer til behandling af immunoinflammatoriske sygdomme |
| UA80957C2 (en) * | 2001-11-01 | 2007-11-26 | Sciclone Pharmaceuticals Inc | Method of administering a thymosin alpha 1 peptide |
| TW200517114A (en) * | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
| WO2007139753A2 (en) * | 2006-05-22 | 2007-12-06 | Combinatorx, Incorporated | Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels |
| CN101594878A (zh) | 2006-09-18 | 2009-12-02 | 雷普特药品公司 | 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗 |
| ITRM20060584A1 (it) * | 2006-10-27 | 2008-04-28 | Francesco Bistoni | Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni |
| JP2012526149A (ja) * | 2009-05-08 | 2012-10-25 | サイクローン・ファーマシューティカルズ・インコーポレイテッド | ワクチン増強剤としてのαチモシンペプチド |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| CN118078979A (zh) | 2011-04-29 | 2024-05-28 | 西莱克塔生物科技公司 | 用于降低针对治疗性蛋白的免疫应答的致耐受性合成纳米载体 |
| US10434088B2 (en) | 2013-05-03 | 2019-10-08 | Selecta Biosciences, Inc. | Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose |
| WO2016037165A1 (en) | 2014-09-07 | 2016-03-10 | Selecta Biosciences, Inc. | Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses |
| CA3055936A1 (en) | 2017-03-11 | 2018-09-20 | Selecta Biosciences, Inc. | Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444757A (en) * | 1981-11-16 | 1984-04-24 | Research Corporation | Use of thymosin as an anti-diabetes and anti-hypertensive disease agent |
| TW224053B (enExample) * | 1991-09-13 | 1994-05-21 | Paul B Chretien |
-
1993
- 1993-10-26 TW TW082108901A patent/TW249754B/zh active
- 1993-10-26 US US08/141,013 patent/US5468729A/en not_active Expired - Lifetime
-
1994
- 1994-10-20 ZA ZA948252A patent/ZA948252B/xx unknown
- 1994-10-21 SG SG1996006784A patent/SG46620A1/en unknown
- 1994-10-21 WO PCT/US1994/012106 patent/WO1995011696A1/en not_active Ceased
- 1994-10-21 AU AU80868/94A patent/AU8086894A/en not_active Abandoned
- 1994-10-24 PH PH49229A patent/PH31319A/en unknown
- 1994-10-25 MY MYPI94002830A patent/MY115157A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH31319A (en) | 1998-07-06 |
| AU8086894A (en) | 1995-05-22 |
| ZA948252B (en) | 1996-04-22 |
| SG46620A1 (en) | 1998-02-20 |
| MY115157A (en) | 2003-04-30 |
| MX9408106A (es) | 1997-09-30 |
| WO1995011696A1 (en) | 1995-05-04 |
| US5468729A (en) | 1995-11-21 |